新型冠状病毒肺炎流行期间儿童心肌炎患者管理建议  

Recommendations for clinical management of children with myocarditis during the epidemic period of COVID-19

作　　者：无 刘桂英[2] 于宪一[3] 陈笋 赵蕾[2] 金红芳[5] 石琳[6] 

机构地区：[1]中国研究型医院学会心血管影像专业委员会儿科学组 [2]首都医科大学附属北京安贞医院 [3]中国医科大学盛京医院 [4]上海交通大学附属新华医院 [5]北京大学第一医院 [6]首都儿科研究所附属儿童医院

出　　处：《中国中西医结合儿科学》2020年第2期96-101,共6页Chinese Pediatrics of Integrated Traditional and Western Medicine

基　　金：国家重大科学仪器设备开发专项(2013YQ03092306);北京市科技计划项目(Z111107067311030);北京市临床重点专科建设项目(2-1-2-18-300)。

摘　　要：2019年12月爆发的新型冠状病毒肺炎疫情,儿童感染病例逐渐增多。流行病学显示所有人群普遍易感,且合并有基础疾病特别是心血管疾病的患者是重症、危重症的高危人群。心肌炎儿童由于既往存在的心肌病变,如心肌纤维化等,合并新型冠状病毒肺炎会为诊疗带来严峻挑战。结合儿童新型冠状病毒肺炎的临床特点及儿童心肌炎的诊治要点,特提出心肌炎儿童新型冠状病毒肺炎的临床管理建议。The outbreak of COVID-19 in December 2019 has spread to all parts of China,and the number of infected children has been increasing.Epidemiology shows that generally all people are susceptible to the virus.The patients with basic diseases,especially cardiovascular diseases,are at high risk of critical diseases.The children with myocarditis have the history of myocardial diseases,such as myocardial fibrosis,so when it is complicated with COVID-19,the diagnosis and treatment face great challenges.Based on the clinical characteristics of COVID-19 and the key points of management of myocarditis in children,we put forward the clinical management recommendations for COVID-19 in children with myocarditis.

关 键 词：新型冠状病毒肺炎 严重急性呼吸道综合征冠状病毒2 心肌炎 管理 儿童 

分 类 号：R725.6[医药卫生—儿科]